Discontinued — last reported Q4 '25
S&P Global Business Sale Proceeds remained flat by 0.0% to $42.00M in Q4 2024 compared to the prior quarter. Year-over-year, this metric declined by 83.4%, from $253.50M to $42.00M. Over 2 years (FY 2022 to FY 2024), Business Sale Proceeds shows a downward trend with a -78.1% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
cf_proceeds_from_sale_of_business| FY'22 | FY'23 | FY'24 | |
|---|---|---|---|
| Value | $3.51B | $1.01B | $168.00M |
| YoY Change | — | -71.1% | -83.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.